NS-089/NCNP-02

· Nippon Shinyaku Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NS-089/NCNP-02, covering 2022-09-29 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study of NS-089/NCNP-02 in DMD [Phase 2]